Akero Therapeutics Inc (AKRO)

Nov 04, 2025

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) - Stock Titan

Nov 04, 2025

Nov 04, 2025

Why (AKRO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Nov 04, 2025

Nov 04, 2025

Will Akero Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - newser.com

Nov 04, 2025

Nov 03, 2025

Can volume confirm reversal in Akero Therapeutics Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com

Nov 03, 2025

Nov 03, 2025

How high can Akero Therapeutics Inc. stock goEarnings Trend Report & Daily Growth Stock Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsPortfolio Return Report & AI Powered Market Entry Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Heatmap analysis for Akero Therapeutics Inc. and competitorsJuly 2025 Patterns & Community Supported Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Is Akero Therapeutics Inc. (0K4) stock a contrarian opportunity - newser.com

Nov 03, 2025

Nov 03, 2025

Can Akero Therapeutics Inc. (0K4) stock beat analyst consensusJuly 2025 Movers & Reliable Entry Point Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Akero Therapeutics Inc. (0K4) stock rise with strong economyTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Akero Therapeutics Inc. stock a buy before product launchesWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com

Nov 03, 2025

Nov 03, 2025

Will Akero Therapeutics Inc. stock gain from lower inflationTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com

Nov 03, 2025

Nov 02, 2025

How rising interest rates impact Akero Therapeutics Inc. stockCEO Change & AI Driven Price Predictions - newser.com

Nov 02, 2025

Nov 02, 2025

Can Akero Therapeutics Inc. (0K4) stock surprise with quarterly resultsWeekly Loss Report & Community Driven Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Will Akero Therapeutics Inc. outperform the marketGap Down & Comprehensive Market Scan Insights - newser.com

Nov 02, 2025

Nov 02, 2025

Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com

Nov 02, 2025

Nov 02, 2025

Using RSI to spot recovery in Akero Therapeutics Inc.Gap Up & Expert Curated Trade Setups - newser.com

Nov 02, 2025

Nov 02, 2025

Chart based analysis of Akero Therapeutics Inc. trendsWeekly Market Outlook & Entry Point Confirmation Signals - newser.com

Nov 02, 2025

Nov 02, 2025

Is Akero Therapeutics Inc. stock a top pick in earnings seasonPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Jennison Associates LLC Grows Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Nov 02, 2025

Nov 02, 2025

Y Intercept Hong Kong Ltd Takes Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Nov 02, 2025

Nov 02, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Update - MarketBeat

Nov 02, 2025

Oct 31, 2025

Fatty liver disease companies' multibillion-dollar deals mean fatter walletsSan Francisco Business Times - The Business Journals

Oct 31, 2025

Oct 31, 2025

Is Akero Therapeutics Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Return Opportunities - newser.com

Oct 31, 2025

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Has $7.27 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Oct 31, 2025

Oct 31, 2025

Is Akero Therapeutics Inc. (0K4) stock included in top ETFsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com

Oct 31, 2025

Oct 31, 2025

Why Akero Therapeutics Inc. stock is recommended by analystsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 31, 2025

Oct 30, 2025

Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha

Oct 30, 2025

Oct 30, 2025

Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant - MSN

Oct 30, 2025